within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G02A_Uterotonics.G02AD03_Gemeprost;

model Gemeprost
  extends Pharmacolibrary.Drugs.ATC.G.G02AD03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>G02AD03</td></tr><td>route:</td><td>vaginal</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Gemeprost is a synthetic methyl ester analogue of prostaglandin E1 used primarily as a vaginal suppository for cervical ripening and to induce abortion or manage miscarriage. It has been used in obstetrics and gynecology, but its use is limited today with preference for other prostaglandins. It is not widely approved or available in most countries currently.</p><h4>Pharmacokinetics</h4><p>No human pharmacokinetic data are available in published literature for gemeprost. Estimated values are based on its class similarity with other prostaglandin E1 analogues used by vaginal administration.</p><h4>References</h4><ol><li><p>Bygdeman, M (2003). Pharmacokinetics of prostaglandins. <i>Best practice &amp; research. Clinical obstetrics &amp; gynaecology</i> 17(5) 707–716. DOI:<a href=&quot;https://doi.org/10.1016/s1521-6934(03)00043-9&quot;>10.1016/s1521-6934(03)00043-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12972009/&quot;>https://pubmed.ncbi.nlm.nih.gov/12972009</a></p></li><li><p>Avrech, OM, et al., &amp; Caspi, E (1991). Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review. <i>Fertility and sterility</i> 56(3) 385–393. DOI:<a href=&quot;https://doi.org/10.1016/s0015-0282(16)54527-0&quot;>10.1016/s0015-0282(16)54527-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1894013/&quot;>https://pubmed.ncbi.nlm.nih.gov/1894013</a></p></li><li><p>Dimov, V, et al., &amp; Christensen, NJ (1986). Metabolism of 16, 16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester (ONO-802) following intravenous and vaginal administration to pregnant women. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 14(4) 494–502. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2873999/&quot;>https://pubmed.ncbi.nlm.nih.gov/2873999</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Gemeprost;
